Making lemonade from SARS coronavirus-2 lemons: Transitioning a smoking cessation trial to a virtual platform
- PMID: 32811627
- PMCID: PMC7403863
- DOI: 10.1016/j.jsat.2020.108100
Making lemonade from SARS coronavirus-2 lemons: Transitioning a smoking cessation trial to a virtual platform
Abstract
Clinical trials represent an essential component of improving treatment for substance use disorders (SUD). The SARS coronavirus-2 pandemic disrupted our ongoing clinical trial of smoking cessation and forced us to rapidly implement changes to assure participants access to ongoing counseling and monitoring via telephone calls and/or video chat sessions. Our experiences suggest that this pandemic will lead to changes for both future clinical trial participants and project staff. While challenges remain, it will be important to assessing the impact of these changes with regard to participant experiences and treatment outcomes.
Copyright © 2020 Elsevier Inc. All rights reserved.
Figures
References
-
- Greenfield S.F., Crisafulli M.A., Kaufman J.S., Freid C.M., Bailey G.L., Connery H.S.…Rodolico J. Implementing substance abuse group therapy clinical trials in real-world settings: Challenges and strategies for participant recruitment and therapist training in the Women’s Recovery Group Study. The American Journal on Addictions. 2014;23(3):197–204. doi: 10.1111/j.1521-0391.2014.12099.x. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
